Lysozyme nephropathy in chronic myelomonocytic leukemia
- PMID: 31183108
- PMCID: PMC6553339
- DOI: 10.1002/ccr3.2188
Lysozyme nephropathy in chronic myelomonocytic leukemia
Abstract
Lysozyme nephropathy is a frequently unrecognized cause of renal disease in chronic myelomonocytic leukemia and may serve as a novel indication for treatment in this patient population. We demonstrate that in newly diagnosed CMML patients, plasma lysozyme levels are positively correlated with both absolute monocyte count and serum creatinine.
Keywords: hematology; nephrology; oncology.
Conflict of interest statement
None declared.
Figures
References
-
- Hayslett JP, Perillie PE, Finch SC. Urinary muramidase and renal disease. Correlation with renal histology and implication for the mechanism of enzymuria. N Engl J Med. 1968;279:506‐512. - PubMed
-
- Cojocel C, Dociu N, Baumann K. Early nephrotoxicity at high plasma concentrations of lysozyme in the rat. Lab Invest. 1982;46:149‐157. - PubMed
LinkOut - more resources
Full Text Sources
